# Cell- Based Noninvasive Prenatal Testing (NIPT): Single Cell Prenatal Diagnosis (SCPD)

> **NCT05076734** · NA · COMPLETED · sponsor: **Luna Genetics** · enrollment: 157 (actual)

## Conditions studied

- Pregnancy Related

## Interventions

- **DIAGNOSTIC_TEST:** Redraw for analysis of blood samples from healthy pregnant women

## Key facts

- **NCT ID:** NCT05076734
- **Lead sponsor:** Luna Genetics
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-12
- **Primary completion:** 2021-12-30
- **Final completion:** 2021-12-30
- **Target enrollment:** 157 (ACTUAL)
- **Last updated:** 2023-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05076734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05076734, "Cell- Based Noninvasive Prenatal Testing (NIPT): Single Cell Prenatal Diagnosis (SCPD)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05076734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*